首页 正文

Advancements in myelofibrosis management: a comprehensive analysis of Ojjaara (Momelotinib) therapy and clinical perspectives

{{output}}
Myelofibrosis (MF) is a rare and progressive blood disorder marked by fibrosis of the bone marrow, abnormal blood cell production, and often severe anemia. The disease is commonly associated with debilitating symptoms such as fatigue, weakness, and an enlarged... ...